Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Public ClinicalTrials.gov record NCT02980133. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler in Patients Aged 4 Through 11 Years With Persistent Asthma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is to evaluate the safety and efficacy of fluticasone propionate and fluticasone propionate salmeterol in pediatric participants with a documented history of persistent asthma.
Study identification
- NCT ID
- NCT02980133
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 841 participants
Conditions and interventions
Conditions
Interventions
- Fluticasone Propionate Drug
- Fluticasone Propionate/Salmeterol Drug
- Placebo MDPI Drug
Drug
Eligibility (public fields only)
- Age range
- 4 Years to 11 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 28, 2016 (Actual)
- Primary completion
- Apr 7, 2019 (Actual)
- Completion
- Apr 13, 2019 (Actual)
- Last update posted
- Nov 9, 2021
2016 – 2019
United States locations
- U.S. sites
- 77
- U.S. states
- 25
- U.S. cities
- 62
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 13881 | Birmingham | Alabama | 35209 | — |
| Teva Investigational Site 13883 | Little Rock | Arkansas | 72205 | — |
| Teva Investigational Site 13906 | Bakersfield | California | 93301 | — |
| Teva Investigational Site 14615 | Corona | California | 92883 | — |
| Teva Investigational Site 13892 | Downey | California | 90241 | — |
| Teva Investigational Site 13875 | Fountain Valley | California | 92708 | — |
| Teva Investigational Site 13904 | Huntington Beach | California | 92647 6818 | — |
| Teva Investigational Site 13877 | Huntington Beach | California | 92648 | — |
| Teva Investigational Site 14668 | Long Beach | California | 90806 | — |
| Teva Investigational Site 13914 | Napa | California | 94558 | — |
| Teva Investigational Site 13918 | Paramount | California | 90723 | — |
| Teva Investigational Site 14618 | Rolling Hills Estates | California | 90274 | — |
| Teva Investigational Site 13912 | Roseville | California | 95661 | — |
| Teva Investigational Site 13847 | Stockton | California | 95207 | — |
| Teva Investigational Site 13848 | Thousand Oaks | California | 91360 | — |
| Teva Investigational Site 13856 | Centennial | Colorado | 80112 | — |
| Teva Investigational Site 13910 | Colorado Springs | Colorado | 80907 | — |
| Teva Investigational Site 13868 | Longmont | Colorado | 80501 | — |
| Teva Investigational Site 13913 | Chiefland | Florida | 32626 | — |
| Teva Investigational Site 14616 | DeLand | Florida | 32720 | — |
| Teva Investigational Site 13909 | Homestead | Florida | 33030 | — |
| Teva Investigational Site 13857 | Loxahatchee Groves | Florida | 33470 | — |
| Teva Investigational Site 13872 | Miami | Florida | 33134 | — |
| Teva Investigational Site 13907 | Miami | Florida | 33134 | — |
| Teva Investigational Site 13893 | Miami | Florida | 33142 | — |
| Teva Investigational Site 13886 | Miami | Florida | 33155 | — |
| Teva Investigational Site 13899 | Miami | Florida | 33175 | — |
| Teva Investigational Site 13864 | Miami | Florida | 33176 | — |
| Teva Investigational Site 13880 | Miami | Florida | 33176 | — |
| Teva Investigational Site 13870 | Miami Lakes | Florida | 33014 | — |
| Teva Investigational Site 14617 | Miami Lakes | Florida | 33015 | — |
| Teva Investigational Site 13916 | Miami Springs | Florida | 33185 | — |
| Teva Investigational Site 13911 | Ocala | Florida | 34471 | — |
| Teva Investigational Site 13876 | Palmetto Bay | Florida | 33157 | — |
| Teva Investigational Site 13844 | Winter Park | Florida | 32789 | — |
| Teva Investigational Site 13866 | Gainesville | Georgia | 30501 | — |
| Teva Investigational Site 13858 | Savannah | Georgia | 31406 | — |
| Teva Investigational Site 13896 | Eagle | Idaho | 83616 | — |
| Teva Investigational Site 13903 | Idaho Falls | Idaho | 83402 | — |
| Teva Investigational Site 13882 | Springfield | Illinois | 62704 | — |
| Teva Investigational Site 13887 | Overland Park | Kansas | 66210 | — |
| Teva Investigational Site 13851 | Owensboro | Kentucky | 42301 | — |
| Teva Investigational Site 13849 | Rockville | Maryland | 20850 | — |
| Teva Investigational Site 13865 | Columbia | Missouri | 65203 | — |
| Teva Investigational Site 13885 | Columbia | Missouri | 65203 | — |
| Teva Investigational Site 13891 | Missoula | Montana | 59808 | — |
| Teva Investigational Site 13897 | Ocean City | New Jersey | 07712 | — |
| Teva Investigational Site 13854 | Verona | New Jersey | 07044 | — |
| Teva Investigational Site 13908 | Watertown | New York | 13601 | — |
| Teva Investigational Site 13890 | Charlotte | North Carolina | 28277 | — |
| Teva Investigational Site 13863 | Raleigh | North Carolina | 27607 | — |
| Teva Investigational Site 13855 | Canton | Ohio | 44718 | — |
| Teva Investigational Site 13905 | Milford | Ohio | 45150 | — |
| Teva Investigational Site 13852 | Oklahoma City | Oklahoma | 73112 | — |
| Teva Investigational Site 13879 | Oklahoma City | Oklahoma | 73112 | — |
| Teva Investigational Site 13884 | Oklahoma City | Oklahoma | 73120 | — |
| Teva Investigational Site 13860 | Tulsa | Oklahoma | 74136 | — |
| Teva Investigational Site 13894 | Tulsa | Oklahoma | 74136 | — |
| Teva Investigational Site 13861 | Medford | Oregon | 97504 | — |
| Teva Investigational Site 13874 | Pittsburgh | Pennsylvania | 15241 | — |
| Teva Investigational Site 13895 | Scottdale | Pennsylvania | 15683 | — |
| Teva Investigational Site 13888 | Providence | Rhode Island | 02909 | — |
| Teva Investigational Site 13871 | Charleston | South Carolina | 29407 | — |
| Teva Investigational Site 13889 | Charleston | South Carolina | 29414 | — |
| Teva Investigational Site 13853 | Spartanburg | South Carolina | 29303 | — |
| Teva Investigational Site 14671 | Summerville | South Carolina | 29483 | — |
| Teva Investigational Site 13898 | Baytown | Texas | 77521 | — |
| Teva Investigational Site 14673 | Boerne | Texas | 78006 | — |
| Teva Investigational Site 13867 | El Paso | Texas | 79903 | — |
| Teva Investigational Site 13902 | Killeen | Texas | 76542-0969 | — |
| Teva Investigational Site 13846 | Live Oak | Texas | 78233 | — |
| Teva Investigational Site 13878 | San Antonio | Texas | 78229 | — |
| Teva Investigational Site 14672 | San Antonio | Texas | 78229 | — |
| Teva Investigational Site 13917 | San Antonio | Texas | 78251 | — |
| Teva Investigational Site 13845 | Waco | Texas | 76712 | — |
| Teva Investigational Site 13850 | Richmond | Virginia | 23223 | — |
| Teva Investigational Site 13915 | Bellingham | Washington | 98225 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02980133, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 9, 2021 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02980133 live on ClinicalTrials.gov.